drugset / Trial / NCT00290030

ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH

NCT00290030

Phase 3 Completed 800 enrolled Sanofi
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the efficacy of alfuzosin 10mg OD in the management of acute urinary retention associated with BPH. To assess the safety of alfuzosin in this population and health care consumption.

Timeline

Start
2001-05
Primary completion
2004-10
Completion
2004-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Alfuzosin Small molecule 10 mg